ClinicalTrials.gg
CompletedNCT06494839Updated Jul 10, 2024

Outcomes of Bipolar Electrocautery Tonsillectomy Versus Cold Steel Dissection Pediatric Tonsillectomy

An interventional study of Bipolar electrocautery tonsillectomy technique and Cold steel dissection technique in Tonsillitis, sponsored by RESnTEC, Institute of Research. Completed at 1 site in Pakistan. Open to participants aged 5 Years to 13 Years. Per ClinicalTrials.gov, last updated 2024-07-10.

Sponsored by RESnTEC, Institute of Research · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 7 months after the study started (first participant enrolled Nov 2023, registered Jun 2024).
Phase
Not applicable
Study type
Interventional
Enrollment
110
Allocation
Randomized
Ages
5 Years to 13 Years
Sex
All
01

Study summary

It was intended to practically establish whether or not the relatively newer technique of tonsillectomy like bipolar electrocautery tonsillectomy has any added benefits in reducing the duration of surgery, blood loss and post-operative pain as compared with conventional cold steel dissection method. This study was done to compare the outcomes of bipolar electrocautery tonsillectomy versus cold steel dissection pediatric tonsillectomy.

02

Conditions studied

  • Tonsillitis

Browse trials for

03

In context

Tonsillitis

103 studies on the registry are indexed under Tonsillitis; 12 are open to participants now.

This study's enrollment of 110 is close to the median of 100 across 87 interventional studies indexed under Tonsillitis.

Browse Tonsillitis studies →

Lead sponsor

RESnTEC, Institute of Research is the lead sponsor of 16 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
5 Years to 13 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients of 5-13 years of age
  • Both genders
  • With a history of recurrent episodes of tonsillitis in the last year
  • Children who had bilaterally enlarged tonsils
  • No history of fever or sore throat in the last 4 weeks

Exclusion criteria

Exclusion Criteria:

  • Patients who had enlarged adenoids and required adenotonsillectomy
  • Patients who underwent tonsillectomy after quinsy
  • With a history of bleeding disorders
  • Patients who showed an (INR) ≥ 1.5
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

INR, PT and aPTT (clotting tests)

Blood tests of how long blood takes to clot. The INR is the prothrombin time (PT) put on a common scale; about 1 is usual for someone not taking a blood thinner.

Criteria often make an exception for people on a blood thinner such as warfarin, whose INR is raised on purpose.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
110 participants (actual)

Study arms

  • Experimental
    Bipolar electrocautery tonsillectomy group

    Procedure: Bipolar electrocautery tonsillectomy technique

  • Experimental
    Cold steel dissection group

    Procedure: Cold steel dissection technique

Interventions

  • ProcedureBipolar electrocautery tonsillectomy technique

    The BED tonsillectomy procedures were done under general anesthesia, and the patient's position was the same as in the other method. The bipolar machine was adjusted to 30 watts, and a mucosal incision was cauterized with a single straight or stepped bipolar forceps. After carefully cauterizing the tissue, the palatine tonsil was located and removed from the superior to the inferior pole. Most of the identifiable vessels supplying the tonsil were cauterized before being separated from the tonsil. Point coagulation was used to maintain hemostasis. By using point coagulation, hemostasis was maintained. To avoid bias stemming from competence, consultants performed all of these tonsillectomies.

  • ProcedureCold steel dissection technique

    The cold steel blunt dissection tonsillectomy was carried out under general anesthesia while the patient was in the Rose position and had an endotracheal intubation. The tonsil was retracted medially with a tonsil holding forceps, and in the upper pole, the mucosal incision was made. To protect the tonsillar pillars, a delicate dissection was performed, and the suction tip was used to stop the hemorrhage. The tonsillar fossa was packed with swabs. The other palatine tonsil was then similarly removed. Hemostasis was secured by silk ligation and bipolar electrocautery.

06

What researchers measure

Primary outcomes

  1. Operative time

    Operative time was measured from the anterior pillar incision to the removal of the mouth gag.

    Time frame: 1 hour

  2. Blood loss

    Intraoperative blood loss was measured by reading the levels given in the suction bottle at the end of surgery. The weight of dry gauze was subtracted from the wet, considering 1g=1ml.

    Time frame: up to 24 hours

  3. Postoperative pain

    Postoperative pain was measured at regular intervals (6-hourly till 24 hours) using the Wong-Baker faces pain rating scale.12 The Wong-Baker faces pain rating scale graded pain as mild (1-3), moderate (4-6), or severe (\>6).

    Time frame: 24 hours

07

Study locations

1 site
  • Sir Ganga Ram Hospital
    Lahore, Punjab 54000, Pakistan
08

References and documents

Individual participant data

Plan to share: No — Data can be shared with other researchers on a reasonable request.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 10, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06494839
Lead sponsor
RESnTEC, Institute of Research
Responsible party
Sponsor
First posted
Jul 10, 2024
Start date
Nov 1, 2023
Primary completion
Apr 30, 2024
Completion
Apr 30, 2024
Last update
Jul 10, 2024

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion